Evidence map›Paper›PMID 33336278›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.

Wai Hon Chooi, Jiah Shin Chin, Sing Yian Chew

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wai Hon ChooiSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Jiah Shin ChinSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Sing Yian ChewSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore. sychew@ntu.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The simple and versatile CRISPR/Cas9 system is a promising strategy for genome editing in mammalian cells. Generally, the genome editing components, namely Cas9 protein and single-guide RNA (sgRNA), are delivered in the format of plasmids, mRNA, or ribonucleoprotein (RNP) complexes. In particular, non-viral approaches are desirable as they overcome the safety concerns posed by viral vectors. To control cell fate for tissue regeneration, scaffold-based delivery of genome editing components will offer a route for local delivery and provide possible synergistic effects with other factors such as topographical cues that are co-delivered by the same scaffold. In this chapter, we detail a simple method of surface modification to functionalize electrospun nanofibers with CRISPR/Cas9 RNP complexes. The mussel-inspired bio-adhesive coating will be used as it is a simple and effective method to immobilize biomolecules on the surface. Nanofibers will provide a biomimicking microenvironment and topographical cues to seeded cells. For evaluation, a model cell line with single copies of enhanced green fluorescent protein (U2OS.EGFP) will be used to validate the efficiency of gene disruption.

Indexed as

CRISPR-Cas SystemsGene EditingTissue ScaffoldsAdhesivesAnimalsCell LineCRISPR-Associated Protein 9Gene ExpressionGene Transfer TechniquesGreen Fluorescent ProteinsLipidsMacromolecular SubstancesNanofibersRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsTissue EngineeringAdhesivesCRISPR-Associated Protein 9enhanced green fluorescent proteinGreen Fluorescent ProteinsLipidsLipofectamineMacromolecular SubstancesRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsCas9 proteinElectrospinningGene deliveryRibonucleoproteinTissue engineering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.